Connect Biopharma Holdings LtdCNTB
Price$0.98Intrinsic value$1.3437% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $3M-88.7% YoYTTM through 30 Jun 2026
Net Income -$69MTTM through 30 Jun 2026
Free Cash Flow -$60.6MTTM through 30 Jun 2026

Margins

Current
Operating Margin-90,681.3%
Net Margin-2,336.3%

Returns

-132.2%ROE
-98.9%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.37x
Net Debt-$44.3Mnet cash position
Cash & Equivalents$27M

Quality Metrics

Altman Z-Score-15.99
Piotroski F-Score1 / 9
FCF Margin-2,053.3%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'23'24'25
FY2025: $64K
Diluted EPS-$1.19TTM
'23'24'25
FY2025: $-1.00

Dividend

No dividend

Capital Allocation

Capex Intensity1.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.